The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types : implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply
| Errataetall: |
CommentOn: Intern Emerg Med. 2020 Nov;15(8):1581-1582. - PMID 32564289 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Internal and emergency medicine - 15(2020), 8 vom: 14. Nov., Seite 1583-1584 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Albini, Adriana [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Angiotensin Receptor Antagonists |
|---|
| Anmerkungen: |
Date Completed 09.11.2020 Date Revised 18.02.2022 published: Print-Electronic CommentOn: Intern Emerg Med. 2020 Nov;15(8):1581-1582. - PMID 32564289 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11739-020-02436-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312426828 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312426828 | ||
| 003 | DE-627 | ||
| 005 | 20231225144407.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11739-020-02436-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1041.xml |
| 035 | |a (DE-627)NLM312426828 | ||
| 035 | |a (NLM)32666177 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Albini, Adriana |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types |b implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.11.2020 | ||
| 500 | |a Date Revised 18.02.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Intern Emerg Med. 2020 Nov;15(8):1581-1582. - PMID 32564289 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Angiotensin Receptor Antagonists |2 NLM | |
| 650 | 7 | |a Antihypertensive Agents |2 NLM | |
| 700 | 1 | |a Noonan, Douglas McClain |e verfasserin |4 aut | |
| 700 | 1 | |a Pelosi, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Di Guardo, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Lombardo, Michele |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal and emergency medicine |d 2006 |g 15(2020), 8 vom: 14. Nov., Seite 1583-1584 |w (DE-627)NLM165086432 |x 1828-0447 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2020 |g number:8 |g day:14 |g month:11 |g pages:1583-1584 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11739-020-02436-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2020 |e 8 |b 14 |c 11 |h 1583-1584 | ||